In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma-Reference-Cited by-同舟云学术

In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma

Published:1983-01 Issue:1 Volume:19 Page:109-122
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Potmesil Milan,Levin Mark,Traganos Frank,Israel Mervyn,Darzynkiewicz Zbigniew,Khetarpal Vinod K.,Silber Robert

Publisher

Elsevier BV

Subject

Oncology

Reference50 articles.

1. Adriamycin: a new drug with significant clinical activity;Blum;Ann Intern Med,1974

2. Daunorubicin and adriamycin;Dimarco,1973

3. Comparative cardiotoxicity studies with adriamycin (ADR) and AD32 in rabbits;Henderson,1978

4. N-Trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin;Israel;Cancer Res,1975

5. N-Trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies;Parker;Cancer Treat Rep,1978

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial report on intraves1cal administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder;Urology;1997-05

2. Phase 1 Trial of Intraperitoneal AD-32 in Gynecologic Malignancies;Gynecologic Oncology;1996-04

3. New anthracycline antitumor antibiotics;Critical Reviews in Oncology/Hematology;1991-03

4. Effects of N-Trifluoroacetyladriamycin-14-O-Hemiadipate and Radiation on L1210 Cells;Radiation Research;1986-02

5. Adriamycin analogs. Rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives;Journal of Medicinal Chemistry;1985-09